Ketoprofen Dompé (Ketoprofen Lysine)

Ketoprofen lysine works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which reduces the synthesis of prostaglandins—key mediators of inflammation, pain, and fever—thereby providing analgesic and anti‑inflammatory effects.

The appropriate dose of Ketoprofen Dompé is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of ketoprofen lysine in pregnancy and lactation has not been firmly established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Ketoprofen Dompé, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoprofen is an NSAID similar to ibuprofen and naproxen but is often considered more potent on a milligram‑per‑milligram basis. Like other NSAIDs, it shares a similar risk profile for gastrointestinal, renal and cardiovascular adverse effects, so choice of agent depends on individual patient factors and clinician judgment.

Ketoprofen Dompé should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ketoprofen Dompé is administered orally. The tablet or capsule should be swallowed whole with a full glass of water, preferably with food or milk to lessen potential gastrointestinal irritation, unless otherwise directed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and renal impairment that may manifest as reduced urine output or worsening kidney function. Patients should seek immediate medical attention if they experience these symptoms.

Ketoprofen Dompé should be avoided in individuals with a known hypersensitivity to ketoprofen or other NSAIDs, active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in patients taking anticoagulants or other NSAIDs without medical supervision. Pregnant women in the third trimester should also refrain from use.